Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival

被引:10
|
作者
Furuse, Hiroshi [1 ]
Matsushita, Yuto [1 ]
Yajima, Takashi [1 ]
Kato, Taiki [1 ]
Suzuki, Takahisa [1 ]
Matsumoto, Rikiya [1 ]
Motoyama, Daisuke [1 ]
Sugiyama, Takayuki [1 ]
Otsuka, Atsushi [1 ]
Ozono, Seiichiro [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Urol, Hamamatsu, Shizuoka, Japan
关键词
kidney pelvis; ureter; urogenital neoplasms; lymph node dissection; survival; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; POSITIVE BLADDER-CANCER; RADICAL CYSTECTOMY; PROGNOSTIC-FACTORS; LYMPHADENECTOMY; IMPACT; NEPHROURETERECTOMY; MULTICENTER; TUMORS;
D O I
10.1093/jjco/hyw179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Unlike for bladder cancer, the impact of regional lymph node dissection for upper tract urothelial carcinoma is unclear. We explored whether patient survival was influenced by systematic regional lymph node dissection, using resection templates according to the main tumor location, during radical nephroureterectomy for upper tract urothelial carcinoma. Methods: The systematic regional lymph node dissection group was defined as cases in which the dissection of nodes and surrounding tissues followed the established template, and the nonsystematic regional lymph node dissection group as cases undergoing limited or no lymph node dissection. We performed radical nephroureterectomy on 98 consecutive patients with various stages of upper tract urothelial carcinoma from May 1994 to September 2014 at our institution. Of these, 77 patients with cTanyN0M0 of upper tract urothelial carcinoma undergoing radical nephroureterectomy were grouped into systematic regional lymph node dissection or non-systematic regional lymph node dissection cohorts according to the extent of dissection, and their outcomes compared. Results: Forty-four patients were categorized as systematic regional lymph node dissection and 33 as non-systematic regional lymph node dissection, including 17 with more limited nodal dissection and 16 with no nodal dissection. Five-year recurrence-free survival and cancer-specific survival were significantly higher in the systematic regional lymph node dissection (93% and 94%, respectively) than in the non-systematic regional lymph node dissection group (75% and 77% recurrence-free survival and cancer-specific survival, respectively). Further, 5-year recurrence-free survival and cancer-specific survival of muscle-invasive upper tract urothelial carcinoma (pT2-4) were significantly higher in the systematic regional lymph node dissection (87% and 91%, respectively) than in the non-systematic regional lymph node dissection group (59% and 62%, respectively) (P = 0.0237 and P = 0.0224). Neither recurrence-free survival nor cancer-specific survival was significantly prolonged by systematic dissection in patients with pTis-1 histology. Conclusions: Systematic regional lymph node dissection during radical nephroureterectomy for cTanyN0M0 upper tract urothelial carcinoma patients has a significantly beneficial impact on survival compared with patients undergoing more limited dissection, especially in the cases involving muscle invasion.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [41] Lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma in the Australian Capital Territory
    Mare, A.
    Mulcahy, M.
    BJU INTERNATIONAL, 2017, 119 : 110 - 110
  • [42] Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
    Lange, Suzanne
    Calleris, Giorgio
    Matin, Surena F.
    Roupret, Morgan
    EUROPEAN UROLOGY FOCUS, 2023, 9 (02): : 280 - 282
  • [43] Lymph Node Dissection During Radical Nephro-Ureterectomy for Upper Tract Urothelial Carcinoma: A Review
    Peyrottes, Arthur
    Califano, Gianluigi
    Ouzaid, Idir
    Laine-Caroff, Paul
    Long Depaquit, Thibaut
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    FRONTIERS IN SURGERY, 2022, 9
  • [44] Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    Tissot, Gabrielle
    Xylinas, Evanguelos
    JOURNAL OF UROLOGY, 2023, 209 (03): : 462 - 463
  • [45] PATIENTS UNDERGOING LYMPH NODE DISSECTION FOR UPPER TRACT UROTHELIAL CARCINOMA HAVE IMPROVED OVERALL SURVIVAL: RESULTS FROM SEER DATABASE
    Daneshvar, Michael
    Daugherty, Michael
    Shapiro, Oleg
    JOURNAL OF UROLOGY, 2019, 201 (04): : E722 - E722
  • [46] Prospective clinical trial of the merits of retroperitoneal lymph node dissection at the time of nephroureterectomy for upper tract urothelial carcinoma
    Rao, S. R.
    Correa, J. J.
    Sexton, W. J.
    Pow-Sang, J. M.
    Spiess, P. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [47] More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
    Mazzone, Elio
    Preisser, Felix
    Nazzani, Sebastiano
    Tian, Zhe
    Fossati, Nicola
    Gandaglia, Giorgio
    Gallina, Andrea
    Soulieres, Denis
    Tilki, Derya
    Montorsi, Francesco
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2019, 17 (02) : 105 - +
  • [48] UTILIZATION OF LYMPHADENECTOMY AND PREDICTORS OF LYMPH NODE YIELD IN UPPER TRACT UROTHELIAL CARCINOMA
    Venkat, Siv
    Lewicki, Patrick
    Basourakos, Spyridon
    Scherr, Douglas
    JOURNAL OF UROLOGY, 2021, 206 : E864 - E865
  • [49] Neoadjuvant Chemotherapy Improves Survival of Patients With Upper Tract Urothelial Carcinoma
    Porten, Sima
    Siefker-Radtke, Arlene O.
    Xiao, Lianchun
    Margulis, Vitaly
    Kamat, Ashish M.
    Wood, Christopher G.
    Jonasch, Eric
    Dinney, Colin P. N.
    Matin, Surena F.
    CANCER, 2014, 120 (12) : 1794 - 1799
  • [50] REGIONAL LYMPH NODE DISSECTION IS ASSOCIATED WITH IMPROVED SURVIVAL FOR PATIENTS WITH UROTHELIAL CELL CARCINOMA UNDERGOING DEFINITIVE SURGERY
    Kohut-Jackson, Abigail L.
    Kumanan, Krithika
    Hamilton, Zachary
    JOURNAL OF UROLOGY, 2024, 211 (05): : E850 - E850